2021 RUNX1 Week Keynote Speaker: Dr. David Fajgenbaum

Dr. David Fajgenbaum, co-founder and CEO of the Castleman Disease Collaborative Network, discusses his personal battle with this rare disease that almost killed him several times, and his tireless research that led to the discovery of a life-saving treatment for himself and many other Castleman patients.

Previous

Crosstalk Between Transcription Factors, Methyltransferases and Tyrosine Kinases

Next

Inherited Thrombocytopenia (ITP): What Is It, Whom To Test and How To Test?